Related Experiment Video
Updated: Feb 16, 2026

Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by Ratiometric FRET
Published on: January 27, 2012
MicroRNA-520a suppresses the proliferation and mitosis of HaCaT cells by inactivating protein kinase B
Rui Wang1, Zigang Zhao1, Liqiang Zheng1
1Department of Dermatology, Chinese People's Liberation Army General Hospital, Medical College of the Chinese People's Liberation Army, Beijing 100853, P.R. China.
Abstract:
Psoriasis is a chronic inflammatory disease of the skin for which an effective treatment strategy remains to be developed. Characteristics of psoriasis include an altered differentiation of keratinocytes and hyperplasia of the skin. The present study aimed to investigate the role served by miR-520a in psoriasis. The results demonstrated that miR-520a inhibited the proliferation of HaCaT cells. miR-520a directly regulated the mRNA and protein expression of its target gene, protein kinase B (AKT). The siRNA silencing of AKT expression in these cells was also evaluated. miRNA-520a repressed the proliferation and mitotic entry of HaCaT cells, and promoted cell apoptosis. AKT silencing suppressed the proliferation of HaCaT cells. These results suggest that miRNA-520a regulates the survival of HaCaT cells by inhibiting AKT expression. miRNA-520a and AKT may therefore be novel targets for the treatment of patients with psoriasis.
Insights
MicroRNA-520a (miR-520a) inhibits skin cell proliferation and promotes apoptosis in psoriasis by targeting protein kinase B (AKT). This suggests miR-520a and AKT are potential therapeutic targets for psoriasis treatment.
Area of Science:
- Dermatology
- Molecular Biology
- Cell Biology
Background:
- Psoriasis is a chronic inflammatory skin disease with poorly understood mechanisms.
- Altered keratinocyte differentiation and skin hyperplasia are key pathological features.
- Current treatment strategies for psoriasis are limited.
Purpose of the Study:
- To investigate the role of microRNA-520a (miR-520a) in the pathogenesis of psoriasis.
- To elucidate the molecular mechanisms underlying miR-520a's function in skin cells.
Main Methods:
- Utilized HaCaT cells (a human keratinocyte cell line) to model psoriasis.
- Assessed the effect of miR-520a on cell proliferation, apoptosis, and mitotic entry.
- Investigated miR-520a's direct regulation of protein kinase B (AKT) at mRNA and protein levels.
- Employed siRNA to silence AKT expression and evaluate its impact on cell behavior.
Main Results:
- miR-520a significantly inhibited HaCaT cell proliferation and mitotic entry.
- miR-520a promoted apoptosis in HaCaT cells.
- miR-520a was found to directly regulate both mRNA and protein expression of AKT.
- Silencing of AKT expression using siRNA also suppressed HaCaT cell proliferation.
Conclusions:
- miR-520a regulates HaCaT cell survival by inhibiting AKT expression.
- miR-520a and AKT represent potential novel therapeutic targets for psoriasis treatment.
More Related Videos
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Mitosis and Cytokinesis
The processes of the cell cycle occur over approximately 24 hours (in typical human cells) and in two major distinguishable stages. The...
X-Inactivation
MicroRNAs
Activation and Inactivation of G Proteins

